Compare MLSS & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | SRTS |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6M | 48.9M |
| IPO Year | 1996 | 2016 |
| Metric | MLSS | SRTS |
|---|---|---|
| Price | $0.47 | $3.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $1.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 158.0K | 40.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,973,982.00 | ★ $27,482,000.00 |
| Revenue This Year | $12.64 | $2.00 |
| Revenue Next Year | $8.99 | $34.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $2.66 |
| 52 Week High | $0.64 | $5.49 |
| Indicator | MLSS | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 50.73 | 54.83 |
| Support Level | $0.24 | $2.80 |
| Resistance Level | $0.48 | $3.81 |
| Average True Range (ATR) | 0.03 | 0.22 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 31.90 | 55.43 |
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.